Showing results (161-170 of 4,754) with videos related to
Sort By:
Pageof 476
Immunogenetics|July 1, 1980
The definition of a new Ia antigenic specificity using the B6.C-H-2bml2 I-region mutant strainG M Morgan, I F McKenzie, R W MelvoldImmunogenetics|July 1, 1980
Studies of H-2Kb mutant mice. I. Description and serological studies of B6.C-H-2bm9, -H-2bm10, and -H-2bm11G M Morgan, I F McKenzie, R W MelvoldJournal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Description of a new Qa antigenic specificity, "Qa-m9," whose expression is under complex genetic controlV R Sutton, P M Hogarth, I F McKenzieJournal of Cardiac Surgery|April 2, 2002
Genetic engineering for xenotransplantationM S Sandrin, B E Loveland, I F McKenzieJournal of Immunological Methods|May 25, 1988
Production of monoclonal antibodies to serum antigens in colorectal carcinomaJ G Teh, C H Thompson, I F McKenzieOccupational and Environmental Medicine|September 19, 2020
Prevalence of exposure to multiple occupational carcinogens among exposed workers in AustraliaJennifer F McKenzie, Sonia El-Zaemey, Renee N CareyJournal of Immunogenetics|February 1, 1989
Cross-linking of Ly 6-linked alloantigens: association between ThB and Ly 5B A Houlden, I F McKenzie, P M HogarthImmunology and Cell Biology|January 1, 1988
Evidence that Thy-1 and Ly-5 (T-200) antigens interact with sulphated carbohydratesC R Parish, P M Hogarth, I F McKenzieCancer Research|July 1, 1988
Increased antitumor effect of immunoconjugates and tumor necrosis factor in vivoM J Smyth, G A Pietersz, I F McKenzieBritish Journal of Cancer|January 1, 1987
The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugatesM J Smyth, G A Pietersz, I F McKenziePageof 476